Friday, 19 July 2024

Singapore includes Novavax XBB.1.5 COVID-19 vaccine under National Vaccination Programme

30 May 2024 | News

For use in Singapore as an option for ages 12 years and above

image credit- shutterstock

image credit- shutterstock

Singapore's Ministry of Health has announced that Novavax/Nuvaxovid XBB.1.5 COVID-19 vaccine will be available under the National Vaccination Programme (NVP).
Eligible individuals can receive the Novavax/Nuvaxovid XBB.1.5 vaccine free of charge at any of the participating general practitioner (GP) clinics offering COVID-19 vaccination.
Following approval by the Health Sciences Authority, the Novavax/Nuvaxovid XBB.1.5 COVID-19 vaccine has been recommended by the Expert Committee on Immunisation for use in Singapore as an option for ages 12 years and above, under prevailing COVID-19 vaccination recommendations.
Persons who are unable to receive the COVID-19 mRNA vaccines are recommended to receive the Novavax/Nuvaxovid XBB.1.5 vaccine (a protein subunit vaccine), except those who were diagnosed with myocarditis/pericarditis after a previous dose of an mRNA vaccine. 
The previous formulation of the Novavax/Nuvaxovid COVID-19 vaccine, which was based on the original COVID-19 strain, had been discontinued from the NVP since 1 January 2024 when the remaining local stock of the vaccine expired and was no longer supplied by the manufacturer.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account